Interest of conventional clinical, biochemical and bioimpedance measurements as indicators of mortality risk in critical patients.
Risk assessment is nowadays an essential part of the management of seriously ill subjects, and multiple scoring methods are available, based on single or preferably multiple determinations. Some of these protocols have been successfully used around the world, and they permit the prediction of outcomes in different clinical populations. However, many indices are labor-intensive or demand an expanded set of biochemical determinations, thus representing an economical burden. Aiming to evaluate the prognostic value of ordinary variables that are already present in the clinical observation, 50 consecutive patients admitted at the intensive care unit were prospectively documented. Methods included clinical (age, sex, stay in ICU, FIO2), biochemical (serum albumin, hemoglobin, glucose, creatinine, WBC count), and bioimpedance variables (resistance, reactance, body impedance coefficient). All these values were registered at admission and before discharge or death, and compared with survival rate. Initially only WBC count was significantly different in survivors, but ongoing documentation revealed that later on, four indices were endowed with prognostic impact: serum album, glucose levels, WBC count and FIO2 requirements. Organ or function-sustaining procedures were also associated with outcome, nominally mechanical ventilation, vasoactive drugs, and enteral/parenteral nutrition. Furthermore, patients submitted to two or three of these methods exhibited higher mortality than those receiving just one, with even better result for those not requiring any. It is concluded that observation of ongoing changes in conventional clinical variables available in the clinical chart are a valid means of estimating the mortality risk in critical cases.